Bond Avillion 2 Development LP

🇬🇧United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website

A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma

Phase 3
Completed
Conditions
Interventions
First Posted Date
2022-08-18
Last Posted Date
2024-08-29
Lead Sponsor
Bond Avillion 2 Development LP
Target Recruit Count
2517
Registration Number
NCT05505734
Locations
🇺🇸

Genesis Clinical Research and Consulting, LLC, Fall River, Massachusetts, United States

🇺🇸

Meridian Clinical Research, LLC, Lincoln, Nebraska, United States

🇺🇸

Mankato Clinic, Mankato, Minnesota, United States

and more 48 locations

To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years.

First Posted Date
2021-04-19
Last Posted Date
2022-05-11
Lead Sponsor
Bond Avillion 2 Development LP
Target Recruit Count
12
Registration Number
NCT04848662
Locations
🇺🇸

IPS Research, Oklahoma City, Oklahoma, United States

🇺🇸

TTS Research, Boerne, Texas, United States

A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis

First Posted Date
2017-12-27
Last Posted Date
2021-08-03
Lead Sponsor
Bond Avillion 2 Development LP
Target Recruit Count
313
Registration Number
NCT03384745
Locations
🇵🇱

Investigative Site, Warszawa, Poland

© Copyright 2024. All Rights Reserved by MedPath